SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer

ClinicalTrials.gov ID: NCT05451004

Public ClinicalTrials.gov record NCT05451004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 5, 2026, 11:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer. A Phase III Randomized Controlled Trial

Study identification

NCT ID: NCT05451004
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Canadian Cancer Trials Group; Network
Enrollment: 510 participants

Conditions and interventions

Conditions

Oropharyngeal Cancer

Interventions

Ipsilateral and Contralateral Neck Radiation
Lymphatic Mapping with SPECT-CT Other

Radiation · Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 9, 2023
Primary completion: Aug 29, 2030
Completion: Aug 29, 2031
Last update posted: Apr 13, 2026

2023 – 2031

United States locations

U.S. sites: 26
U.S. states: 11
U.S. cities: 22

Facility	City	State	ZIP	Site status
City of Hope Corona	Corona	California	92882	Recruiting
City of Hope Comprehensive Cancer Center	Duarte	California	91010	Recruiting
City of Hope at Irvine Lennar	Irvine	California	92618	Suspended
UM Sylvester Comprehensive Cancer Center at Coral Gables	Coral Gables	Florida	33146	Recruiting
Baptist MD Anderson Cancer Center	Jacksonville	Florida	32207	Active, not recruiting
University of Miami Miller School of Medicine-Sylvester Cancer Center	Miami	Florida	33136	Recruiting
Moffitt Cancer Center-International Plaza	Tampa	Florida	33607	Recruiting
Moffitt Cancer Center - McKinley Campus	Tampa	Florida	33612	Recruiting
Moffitt Cancer Center	Tampa	Florida	33612	Recruiting
Emory University Hospital Midtown	Atlanta	Georgia	30308	Recruiting
Northwestern University	Chicago	Illinois	60611	Active, not recruiting
Northwestern Medicine Cancer Center Warrenville	Warrenville	Illinois	60555	Active, not recruiting
The James Graham Brown Cancer Center at University of Louisville	Louisville	Kentucky	40202	Suspended
University of Michigan Rogel Cancer Center	Ann Arbor	Michigan	48109	Recruiting
University of Michigan - Brighton Center for Specialty Care	Brighton	Michigan	48116	Recruiting
Henry Ford Hospital	Detroit	Michigan	48202	Recruiting
MU Health - University Hospital/Ellis Fischel Cancer Center	Columbia	Missouri	65212	Recruiting
UNC Lineberger Comprehensive Cancer Center	Chapel Hill	North Carolina	27599	Recruiting
Providence Portland Medical Center	Portland	Oregon	97213	Recruiting
MD Anderson in The Woodlands	Conroe	Texas	77384	Recruiting
M D Anderson Cancer Center	Houston	Texas	77030	Recruiting
MD Anderson West Houston	Houston	Texas	77079	Recruiting
MD Anderson League City	League City	Texas	77573	Recruiting
MD Anderson in Sugar Land	Sugar Land	Texas	77478	Recruiting
University of Vermont Medical Center	Burlington	Vermont	05401	Recruiting
University of Vermont and State Agricultural College	Burlington	Vermont	05405	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05451004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 13, 2026 · Synced May 5, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05451004 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →